Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Invested Capital (2021 - 2025)

Historic Return on Invested Capital for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Q3 2025 value amounting to 0.26%.

  • Maravai Lifesciences Holdings' Return on Invested Capital fell 3800.0% to 0.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.26%, marking a year-over-year decrease of 3800.0%. This contributed to the annual value of 0.21% for FY2024, which is 2200.0% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Return on Invested Capital stood at 0.26%, which was down 3800.0% from 0.4% recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Return on Invested Capital ranged from a high of 0.5% in Q1 2022 and a low of 0.4% during Q2 2025
  • Moreover, its 5-year median value for Return on Invested Capital was 0.14% (2023), whereas its average is 0.14%.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Return on Invested Capital skyrocketed by 2700bps in 2022 and then crashed by -4100bps in 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Return on Invested Capital (Quarter) stood at 0.48% in 2021, then fell by -23bps to 0.36% in 2022, then tumbled by -99bps to 0.01% in 2023, then plummeted by -4590bps to 0.23% in 2024, then decreased by -10bps to 0.26% in 2025.
  • Its Return on Invested Capital stands at 0.26% for Q3 2025, versus 0.4% for Q2 2025 and 0.31% for Q1 2025.